Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02410564 · ClinicalTrials.gov registry record · NA
CBT-I Intervention for Insomnia in Newly Diagnosed Cancer Patients
A NA study, sponsored by Virginia Commonwealth University.
- Terminated
- Registry status
- NA
- Development phase
- 29
- Enrollment target
NCT02410564 is a NA study that was terminated before completion, run by Virginia Commonwealth University. The registered enrollment target is 29 participants.
The verdict
NCT02410564, a NA study, was terminated before completion, sponsored by Virginia Commonwealth University.
- TERMINATED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
Study Summary
To determine the efficacy of a CBT-I intervention in improving sleep and other quality of life outcomes during cancer treatment. To assess the feasibility and acceptability of a CBT-I intervention among newly diagnosed cancer patients.
Interventions
- BEHAVIORAL cognitive behavioral therapy for insomnia (CBTI)
- BEHAVIORAL Waitlist control condition
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2014-12 |
| Est. Completion | 2016-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02410564
The ClinicalTrials.gov registry entry for NCT02410564 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which cognitive behavioral therapy for insomnia (CBTI) is the first listed.
NCT02410564 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02410564 about?
NCT02410564 is a clinical study titled "CBT-I Intervention for Insomnia in Newly Diagnosed Cancer Patients". To determine the efficacy of a CBT-I intervention in improving sleep and other quality of life outcomes during cancer treatment. To assess the feasibility and acceptability of a CBT-I intervention among newly diagnosed cancer patients.
What is the current status of trial NCT02410564?
This trial is currently terminated. It is a NA study. The enrollment target is 29 participants. The study started on 2014-12. Estimated completion is 2016-01.
What interventions are being tested in trial NCT02410564?
The interventions under investigation include: cognitive behavioral therapy for insomnia (CBTI) (BEHAVIORAL), Waitlist control condition (BEHAVIORAL).
Who is sponsoring clinical trial NCT02410564?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.